Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion

Kenvue's stock was cheered in its Wall Street debut Thursday, as the J&J spinoff saw its stock open 16.0% above where the initial public offering was priced.